These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 26188831)
1. Drug-eluting stent treatment of left main coronary artery disease: the case for a sirolimus-eluting, autoexpandable alternative. An optical coherence tomography analysis. Buccheri D; Orrego PS; Cortese B Int J Cardiol; 2015 Nov; 199():119-20. PubMed ID: 26188831 [No Abstract] [Full Text] [Related]
2. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining. Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265 [TBL] [Abstract][Full Text] [Related]
4. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327 [TBL] [Abstract][Full Text] [Related]
5. First-in-man unprotected left main stenting with Stentys Xposition S self-apposing sirolimus eluting stent and optical coherence tomography guidance: The emerging panacea for left main intervention. Yew KL; Kang Z Int J Cardiol; 2015 Dec; 201():628-30. PubMed ID: 26340130 [No Abstract] [Full Text] [Related]
6. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A; J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982 [TBL] [Abstract][Full Text] [Related]
7. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up. Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536 [TBL] [Abstract][Full Text] [Related]
8. Late acquired double lumina in a sirolimus-eluting stent recanalized chronic total occlusion lesion: angiographic and optical coherence tomographic findings. Wu W; Zhang S; Shen Z; Xie H; Fan Z Int J Cardiol; 2013 Apr; 165(1):206-8. PubMed ID: 22995412 [No Abstract] [Full Text] [Related]
9. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography. Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964 [TBL] [Abstract][Full Text] [Related]
10. Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial). Kubo T; Akasaka T; Kozuma K; Kimura K; Kawamura M; Sumiyoshi T; Ino Y; Morino Y; Tanabe K; Kadota K; Kimura T; EuroIntervention; 2015 Sep; 11(5):564-71. PubMed ID: 26390517 [TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial. Adriaenssens T; Dens J; Ughi G; Bennett J; Dubois C; Sinnaeve P; Wiyono S; Coosemans M; Belmans A; D'hooge J; Vrolix M; Desmet W EuroIntervention; 2014 Aug; 10(4):439-48. PubMed ID: 25138182 [TBL] [Abstract][Full Text] [Related]
12. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1. Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447 [TBL] [Abstract][Full Text] [Related]
13. Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: results from the ISAR-DESIRE 2 trial. Kufner S; Byrne RA; de Waha A; Schulz S; Joner M; Laugwitz KL; Kastrati A; Cardiovasc Revasc Med; 2014 Mar; 15(2):69-75. PubMed ID: 24684757 [TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomographic observations of polytetrafluoroethylene-covered sirolimus-eluting coronary arterial stent. Hou J; Jia H; Huang X; Yu H; Ren X; Fang Y; Han Z; Yang S; Meng L; Zhang S; Yu B; Jang IK Am J Cardiol; 2013 Apr; 111(8):1117-22. PubMed ID: 23351458 [TBL] [Abstract][Full Text] [Related]
16. Contribution of organized thrombus to in-stent restenosis after sirolimus-eluting stent implantation: optical coherence tomography findings. Fujii K; Masutani M; Ohyanagi M Eur Heart J; 2008 Jun; 29(11):1385. PubMed ID: 18077442 [No Abstract] [Full Text] [Related]
17. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study. Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717 [TBL] [Abstract][Full Text] [Related]
18. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents. Moore P; Barlis P; Spiro J; Ghimire G; Roughton M; Di Mario C; Wallis W; Ilsley C; Mitchell A; Mason M; Kharbanda R; Vincent P; Sherwin S; Dalby M JACC Cardiovasc Interv; 2009 May; 2(5):437-44. PubMed ID: 19463468 [TBL] [Abstract][Full Text] [Related]
19. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial. Kandzari DE; Rao SV; Moses JW; Dzavik V; Strauss BH; Kutryk MJ; Simonton CA; Garg J; Lokhnygina Y; Mancini GB; Yeoh E; Buller CE; JACC Cardiovasc Interv; 2009 Feb; 2(2):97-106. PubMed ID: 19463409 [TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up. Kim BK; Hong MK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y Int J Cardiol; 2013 Oct; 168(5):4617-23. PubMed ID: 23932862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]